Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP & Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $101.09 · Expires 2032-04-01 | Direct | 25,987 |
Reported balance
After 2022-04-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-04-01 · Grant · Acquired 25,987 · Balance 25,987 F1: Option becomes exercisable in four equal installments, commencing 4/1/2023. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 161,318 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 161,318 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 200,358 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 200,358 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 248,131 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 248,131 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 303,010 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 303,010 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 239,355 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 239,355 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 172,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 172,772 F9: Option becomes exercisable in four equal installments, commencing 4/1/2022. |
| Common StockSEC Table I · non-derivative | Direct | 426,024.717 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 426,024.717 |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 38,192 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,192 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 12,812 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 12,812 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 6,155.5059 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,155.5059 |
| Stock UnitSEC Table I · non-derivative | Direct | 341,392.3767 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 341,392.3767 |
| Phantom Stock CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 1,416.3128 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,416.3128 F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Option becomes exercisable in four equal installments, commencing 4/1/2023.
F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 5, 2022 21:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 25,987 | $101.09 Strike: $101.09 | $2,627,025.83 |
DisclosureSEC source: 0001127602-22-011608 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,987 Underlying: Common Stock · 25,987 shares Expires 2032-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2023. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 322,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006308 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,024.717 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 68,482 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,482 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 68,482 | $107.50 | $7,361,815.00 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,114.717 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 68,482 | $102.26 | $7,002,969.32 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,596.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 108,870 | $0.00 Strike: $45.93 | $0.00 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,870 shares Expires 2022-09-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/4/2015. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 108,870 | $95.00 | $10,342,650.00 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,114.717 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 108,870 | $45.93 | $5,000,399.10 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,984.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 172,772 | $74.30 Strike: $74.30 | $12,836,959.60 |
DisclosureSEC source: 0001127602-21-012812 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,772 Underlying: Common Stock · 172,772 shares Expires 2031-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 79,714 | $74.30 | $5,922,750.20 |
DisclosureSEC source: 0001127602-21-012812 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,760.717 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| March 26, 2021 Filed Mar 29, 2021 22:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 73,433 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-21-012257 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,433 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| March 26, 2021 Filed Mar 29, 2021 22:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 73,433 | $74.49 | $5,470,024.17 |
DisclosureSEC source: 0001127602-21-012257 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663.717 F1 · kind: All sales were effected pursuant to Rule 10b5-1 plan. Read SEC document |
| March 26, 2021 Filed Mar 29, 2021 22:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 73,433 | $74.29 | $5,455,337.57 |
DisclosureSEC source: 0001127602-21-012257 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,096.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Apr 2, 2021 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 175,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012812 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,474.717 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 239,355 | $58.61 Strike: $58.61 | $14,028,596.55 |
DisclosureSEC source: 0001127602-20-013222 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,355 Underlying: Common Stock · 239,355 shares Expires 2030-04-01 F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 7, 2020 21:33 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 239,355 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-20-013402 · form4a.xml · derivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,355 Underlying: Common Stock · 239,355 shares Expires 2030-04-01 F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 63,366 | $59.18 | $3,749,999.88 |
DisclosureSEC source: 0001127602-20-009167 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,406.0608 F1 · shares: Consists of Stock Units Awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 68,844 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-20-001407 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,844 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 57,563 | $72.63 | $4,180,800.69 |
DisclosureSEC source: 0001127602-20-001407 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,044.6311 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $71.75 and 73.04 per share. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 22:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 68,844 | $54.53 | $3,754,063.32 |
DisclosureSEC source: 0001127602-20-001407 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,607.6311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:47 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 303,010 | $54.19 Strike: $54.19 | $16,420,111.90 |
DisclosureSEC source: 0001127602-19-014647 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,010 Underlying: Common Stock · 303,010 shares Expires 2029-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 27,183 | $57.83 | $1,571,992.89 |
DisclosureSEC source: 0001127602-19-009278 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,188.4985 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 77,639 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-19-003734 · form4.xml · derivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 77,639 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 77,639 | $64.54 | $5,010,821.06 |
DisclosureSEC source: 0001127602-19-003734 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,763.6311 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $62.93 and $65.30 per share. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 77,639 | $45.07 | $3,499,189.73 |
DisclosureSEC source: 0001127602-19-003734 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,402.6311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 248,131 | $62.21 Strike: $62.21 | $15,436,229.51 |
DisclosureSEC source: 0001127602-18-013801 · form4.xml · derivative · entry 5 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,131 Underlying: Common Stock · 248,131 shares Expires 2025-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 5,979 | $67.73 | $404,957.67 |
DisclosureSEC source: 0001127602-18-009707 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,911.2079 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| November 08, 2017 Filed Feb 9, 2018 22:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 222 | $68.99 | $15,315.78 |
DisclosureSEC source: 0001127602-18-004968 · form5.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,762.5252 Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 85,743 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,743 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 85,743 | $83.14 | $7,128,673.02 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,812.1293 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $82.89 and $83.35 per share. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 20:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 85,743 | $34.96 | $2,997,575.28 |
DisclosureSEC source: 0001127602-17-027732 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,555.1293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 200,358 | $78.05 Strike: $78.05 | $15,637,941.90 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,358 Underlying: Common Stock · 200,358 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 25,624 | $78.05 | $1,999,953.20 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,780 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,655 | $78.50 | $365,417.50 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,812.1293 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 21,717 | $80.58 | $1,749,955.86 |
DisclosureSEC source: 0001127602-17-009680 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,442.4939 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 61,196 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-17-006904 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,196 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/1/2011. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 61,196 | $80.00 | $4,895,680.00 |
DisclosureSEC source: 0001127602-17-006904 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,759.1293 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 61,196 | $36.23 | $2,217,131.08 |
DisclosureSEC source: 0001127602-17-006904 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,955.1293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 161,318 | $104.82 Strike: $104.82 | $16,909,352.76 |
DisclosureSEC source: 0001127602-16-048878 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,318 Underlying: Common Stock · 161,318 shares Expires 2023-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 21,465 | $104.82 | $2,249,961.30 |
DisclosureSEC source: 0001127602-16-048878 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,753 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 16,748 | $97.17 | $1,627,403.16 |
DisclosureSEC source: 0001127602-16-044567 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,063.1322 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 11, 2016 Filed Feb 11, 2016 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 23,355 | $92.86 | $2,168,745.30 |
DisclosureSEC source: 0001127602-16-040730 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,643.5258 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $92.54 and $93.11 per share. Read SEC document |
| November 12, 2015 Filed Feb 11, 2016 22:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 175 | $93.12 | $16,296.00 |
DisclosureSEC source: 0001127602-16-040730 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,998.5258 Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,654 | $102.71 | $478,012.34 |
DisclosureSEC source: 0001127602-15-013953 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,087.0256 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 68,482 | $102.26 Strike: $102.26 | $7,002,969.32 |
DisclosureSEC source: 0001127602-15-013953 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,482 Underlying: Common Stock · 68,482 shares Expires 2022-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,778 | $102.26 | $999,898.28 |
DisclosureSEC source: 0001127602-15-013953 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,753 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| March 02, 2015 Filed Mar 3, 2015 22:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 98 | $104.19 | $10,210.62 |
DisclosureSEC source: 0001127602-15-009639 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,034.0256 Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 15,644 | $103.87 | $1,624,942.28 |
DisclosureSEC source: 0001127602-15-009639 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,132.0256 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 86,487 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · derivative · entry 8 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,487 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/1/2009. Read SEC document |
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 86,487 | $95.31 | $8,243,075.97 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,467.7177 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.67 and $95.70 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.